Table 2.
Model | Total cohort (n = 1,070)
|
Normal fasting glucose and normal glucose tolerance (n = 517)
|
Normal fasting glucose, normal glucose tolerance, and GFR>50 ml/min per 1.73m2 (n = 433)
|
|||
---|---|---|---|---|---|---|
β coefficient (95% CI) | P | β coefficient (95% CI) | P | β coefficient (95% CI) | P | |
A | 0.86 (0.53–1.19) | <0.001 | 1.03 (0.57–1.50) | <0.001 | 0.52 (0.11–0.93) | 0.01 |
B | 1.10 (0.67–1.53) | <0.001 | 0.79 (0.25–1.33) | 0.004 | 0.54 (0.07–1.00) | 0.02 |
C | 0.85 (0.52–1.19) | <0.001 | 1.03 (0.56–1.56) | <0.001 | 0.55 (0.14–0.97) | 0.01 |
D | 0.88 (0.45–1.31) | <0.001 | 1.09 (0.51–1.67) | <0.001 | 0.61 (0.11–1.10) | 0.02 |
E | 1.19 (0.69–1.68) | <0.001 | 0.86 (0.23–1.49) | 0.007 | 0.66 (0.12–1.19) | 0.02 |
Data are regression coefficients for a 1-unit higher M/I. Model A is adjusted for age, model B is adjusted for age and glucometabolic factors (fasting plasma glucose, fasting plasma insulin, and 2-h plasma glucose at OGTT), model C is adjusted for age and cardiovascular risk factors (hypertension, dyslipidemia, and smoking), model D is adjusted for age and lifestyle factors (BMI, physical activity, and consumption of tea, coffee and alcohol), and model E is adjusted for all covariates in models A–D.